Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit

Infection Control and Hospital Epidemiology

Volumn 32, Issue 8, 2011, Pages 815-817

  Seiter, Karen ^a   Shah, Dhaval ^a   Sandoval, Claudio ^a   Liu, Delong ^a   Nadelman, Robert B ^a   Sinaki, Banafsheh ^a   Cuffari, Cristina ^a   Shi, Qiuhu ^a   Abid, Syed ^b   Montecalvo, Marisa ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Westchester County Department of Laboratories and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; ACUTE LEUKEMIA; ADULT; ANTIVIRAL THERAPY; APLASTIC ANEMIA; ARTICLE; CANCER CENTER; CANCER PATIENT; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COUGHING; DIARRHEA; DYSPNEA; FEMALE; FEVER; HEADACHE; HUMAN; LYMPHOMA; MALE; MYALGIA; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SOLID TUMOR; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; CHILD; FEVER; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MIDDLE AGED; NEOPLASMS; ONCOLOGY SERVICE, HOSPITAL; OSELTAMIVIR; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960740179     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/661105     Document Type: Article

References (10)

1. Seiter K, Nadelman RB, Liu D, Ahmed T, MontecalvoMA. Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol 2010;28:e27-e29.
2. Jain S, Kamimoto L, Bramley AM, et al, and the Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-1944.
3. Redelman-Sidi G, Sepkowitz KA, Huang CK, et al. H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010;60:257-263.
4. Englund J, Pergam S, Kuypers J, et al. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunocompromised patients-Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009;58:893-896.
5. Kharfan-Dabaja MA, Velez A, Richards K, et al. Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol 2010;91:124-127.
6. Chan PA, Connell NT, Gabonay AM, et al. Oseltamivir resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient. Clin Microbiol Infect 2010;16:1576-1578.
7. Harvala H, Gunson R, Simmonds P, et al. The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December 2009. Euro Surveill 2010;15:19536.
8. Tramontana AR, George B, Hurt AC, et al. Oseltamivir resistance in adult oncology and hematology patients with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010;16: 1068-1075.
9. Liu C, Schwartz BS, Vallabhaneni S, et al. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis 2010;16:1910-1917.
10. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Vol 2. Prevention and treatment of cancer-related infections. 2009. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.